Pharma Sector - Understanding Entire Value Chain

In this comprehensive video, we delve into the intricate details of the entire value chain of the Pharma sector. From research and development to production, marketing, and distribution, we explore every stage in the process of bringing pharmaceutical products to the market. Gain a deep understanding of the complex network involved in the Pharma industry as we dissect the supply chain, regulatory environment, and various stakeholders' roles. Whether you are an industry professional, investor, or simply curious about the workings of this vital sector, this video provides invaluable insights
00:00 Introduction
01:15 Global Pharma Market (USD B)
03:57 Global Pharma Market - Innovators vs Generic (US$ billion)
06:38 PHARMA VALUE CHAIN
09:19 R&D
14:40 Estimated Market Spending vs Outsourced Spend 2017
17:56 R&D Outsourcing From India
25:41 ANDA approvals from US FDA
27:27 R&D as a % of Sales
28:13 Manufacturing
33:10 CDMO, CRO & CRAMS
35:18 CRAMS INDUSTRY
37:20 Indian Player in CRAMS Industry
40:36 Overview of API industry in India
44:16 Indian Players’ US Business
45:44 Indian Branded
46:55 Indian Pharma Value Chain (%MRP Build up)
47:37 IPM-Acute vs Chronic
48:46 IPM by Therapy
50:50 Key Players in the OTC market in India
53:14 IPM - Average NLEM contribution in IPM sales
53:57 Biggest Pharma
Complete Fundamental Stock Analysis Tool - Stock-o-meter:
investyadnya.in/stock-o-meter
Research Based Ready-made Model Portfolios:
investyadnya.in/model-portfolios
Comprehensive Mutual Fund Reviews:
investyadnya.in/fund-o-meter
Yadnya Books and eBooks now available:
On Amazon - amzn.to/2XKtlks
On our website - investyadnya.in/books
Find us on Social Media and stay connected:
Blog - blog.investyadnya.in
Telegram - t.me/InvestYadnya
Facebook Page - / investyadnya
Facebook Group - goo.gl/y57Qcr
Twitter - / investyadnya
LinkedIn - / investyadnya
#PharmaSectorExplained #ValueChainInPharma #PharmaceuticalProducts #IndustryInsights #PharmaMarketTrends #ExplorePharmaIndustry #PharmaceuticalSupplyChain #RegulatoryEnvironment
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.

[@jayjethva5755]

Most underrated channel in youtube for finance aspirants

[@GauravTak05]

As a final year B Pharm student I would say spending 55 minutes is worth it. Amazing analysis. Thank you

[@marodiak]

Fantastic - very good coverage in all ways

[@navneetmukherjee9592]

Your look and your analytical brain game both are simply out of the world collection. I learned a lot, a lot - from you.
Thank you sir- one of the best value adding series of TH-cam

[@devalpatel552]

It seems like you are Pharma domain expert. Very well explained.
Sir, we need banking and hotel industry knowledge as same like this video

[@govindnandwana8870]

Every minute of the video was worth watching.

[@civilshort13]

Thank u sir. Clearly explained. I didnt know how pharm sector work. Now i knew clear explanation.

[@pradipghosh1934]

Excellent analysis and presentation in lucid language. Thank you so much 🙏

[@165samir]

Great video.Till now I have watched this video 5 times in two days. Finally noted every important thing. It was really a much needed video for me as I got very much perplexed whenever I read about any Pharma company. Keep doing such good work sir.

[@kishorepanjabi5202]

Thanks for giving us amazing knowledge about Pharma sector

[@harshagrawal3989]

Realy admire your value chain series

[@rakeshg133]

Excellent video . Cleared concept

[@romeshkirpalani848]

Excellent job, thank you and kudos for your efforts❤

[@abhishekkasat545]

explained in great detail with all the data and sources

[@pramodtsrinivasula6283]

very informative. Bahut badiya

[@surinderpathania3052]

Your value chain videos are very helpful. Thankyou for making these types of videos for us.❤

[@abdullasajwani3874]

Thank You Sir, Great Video It real Helped a lot to Undertand Pharma Sector.Every one Must watch it befor investing in Pharma sector.

[@sunilkhanduri7927]

Excellent research sir
Thanks a lot

[@saurabhbhardwaj1511]

Best explanation !

[@anjalishaw6580]

Thank you sir for such amazing information..😊

[@vikramchandel3732]

Very informative video. ...A matured channel.

[@npummy]

Excellent presentation

[@nootropics11]

Excellent video Sir! I am being pharma professional, corelate well.❤

[@ajaykhimnani266]

Wonderful Analysis

[@UtkarshMule-xr5mm]

Wonderful session sir

[@debamahata9240]

Awesome discussion 👏 👌 👍

[@satishrdighe1]

Very well explained for a layma. Especially the terms used in the pharma industry.

[@gouthampai5055]

Thank you gaurav sir

[@sanjaykaila4073]

Great Pharma teacher

[@kamalsharma3663]

Great effort

[@rajumondal2658]

Good evening sir.. I love your analysis very much..

[@rahulmane1449]

Thank you

[@krishnaprassad4232]

Very good analysis, with facts and figures presented very effectively.....Thank You

[@ratneshwarpawar5304]

Great effort 💯 👍🎉

[@surajis2good]

Great video, thanks for making it.

[@vdhanasekaran9387]

Sir very useful information.

[@dilipvangal]

Excellent analysis

[@afreenansari1591]

Thank you sir 🙏

[@gowdablr]

Great Video. Indepth analysis. Keep it up.

[@prof.vinodkumargupta7958]

Very effective transaction of information on Pharma sector. It is useful to me to select Pharma companies for investment purpose

[@aniketraje4430]

Gaurav Brilliant 👏 👌

[@user-fk3oz2zk6h]

Very insightful and useful video sir, please keep uploading such high quality content

[@manglamsales3605]

THANK YOU SO MUCH SIR

[@rahulagrawal8971]

Very good video have ever seen.

[@bhupendrasonawane8514]

It was very informative.

[@lifeistoshort2103]

What a informative video❤

[@lok-aarpandreamhosing8977]

Thanks 🙏

[@robairtrader]

Very good

[@SB-ft5hs]

Thank you for enhancing our knowledge ❤

[@shantilalpatel6875]

😊😊

[@Vivek788]

Wow.. this was really well researched and explained in easy terms( considering the complexity of the sector). I only wish some time could have been spent on the chemical ingredients and their manufacturers.

[@dragonprince7]

Subah subah uthke dekha
Felt good

[@biohimanshu]

So much interesting more then movie, wow

[@mukgrg485]

Gained from ur presentation 👍🏼

[@vinitkulkarni4197]

Sir thanks

[@user-rk2eq6fw2j]

Awesome video..
I appreciate the effort that you people have put in to provide this quality content.
I am sure that this kind of summarised content is not available in youtube.
Its very sad to see that people give millions of views to the videos with title `How I made 1 crore with trading?` and not watching this kind of valuable videos.
There kind of videos can be good starting point for the people what wants to learn more about particular sector.

[@deepakprabhu7889]

Absolutely right

[@LNJP13579]

Very true !

[@devangsarawgi31]

Sir, there is mis-information regarding form 483
Form of 483 is issued after every inspection by US FDA. USFDA specifies its list of observations in form 483. Company submits capa plan answering their response to the USFDA,observations
If the regulator is satisfied, it issues NAI certificate
if the regulator is satisfied but want to further reinspect it issues VAI
If the regulator is not satisfied, it issues OAI status
Even after OAI status, medicines can be exported to the US market but if regulator is not satisfied, it issues, warning letter and import alert Signifying ban of drug import from that plant into USA

[@biohimanshu]

Give it name master class

[@CMAVenktesh]

Sir kindly make a playlist of value chain analysis

[@aruntrivedi2817]

I am also pharmacist. Apka pharma value chain ya pharma business ka knowledge acha hai..

[@aloksingh-xw1uh]

Sir please we need more videos on pharma marketing❤

[@navneetmukherjee9592]

Sir it is really really helpful to understand the Pharma sector in and out.
Sir, will it be possible to go deeper into R&D and Manufacturing separately.... doesn't matter how long the videos are ....as long as you are delivering your insights - it seems that time has glided by rather too soon

[@navneetmukherjee9592]

Expected a reply from you Sir

[@rounakprasad1852]

There is also patent term extension for 5 years after patent expires.
Also, exclusivity depends on the drug. whether it is a rare disease drug or normal drug.

[@42najibshaikh98]

Excellent explanation, one small request sir plz provide ppt

[@RAKESHYADAV-ht2qp]

very nice video...use markers in ppt

[@wealthenterprises7519]

What valuation multiple should be ideal for domestic as well as global pharma indian co

[@devangsarawgi31]

Zydus life is also big into R&D
It is itself doing Pharma 3 clinical trial for its NDA Drug Saroglitizar
This drug is approved in India by Indian drug regulators and is among top 10 selling drug brand in india with fast growth and adoption among patients

[@nazeemummer1]

👌

[@unknownk8738]

One of the best video ever. So nicely explained and in simple words at good pace.... Amazing, please keep creating such videos.
Request you to make such videos on speciality chemicals

[@shivkumarawasthi5797]

Please give information information about USA Pharma company 🙏

[@boredinloop]

Have api earning capitalised more in the past barring covid-19 than formulation the earnings for incremental revenue growth and profitability?

[@sudipdutta7510]

Please refer the best company to buy now

[@jayeshsinghvi5630]

Company wise revenue of chronic medicines business??

[@hemantupadhyay1554]

Sir please do IT sector analysis

[@pranjulgupta9250]

Sir can you please clear my doubt about which pharma company is biggest - I taght its Dr Reddy but you said its sun pharma , can you plz explain it further is on the basis on Inidan market or On basis on B2B or B2C basis?

[@ydharmus]

What is api and formulation in common man terms pls. What is the difference?

[@javidkathroo]

Ipca, cipla, sun, aurobindo, divis lab , alkem

[@sombirsingh3329]

Sir gland pharma ka naam nhi h kya?

[@Zeeshanali-hl4uv]

Next value chain konsi karenge???

[@krishnadasanpalaniswamy6170]

Would be great if you could do the video in English

[@PankajkumarSaini-cl4zx]

Thank you sir. Sir mae b pharm from maharishi arvind institute of pharmacy

[@aksheypatil6479]

Chemical Sector please

[@sagarbanik5011]

Where is Divis Lab

[@patu8mukhuti]

Paracetamol is a pain killer. Not antiinfective

[@9986095512]

Jo chal rahaa hai vo sab batate hain, magar aisaa sector lavo jo future mein chalne wala ho, starting mein invest karein to madad milegaa. Please

[@9986095512]

Jab se news aaya pharma negative return?

[@basantshrivastava7781]

Excellent research sir
Thanks a lot

[@chaitanyaksk90]

Thank you